Literature DB >> 18755602

Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy.

Kwang-Hun Lee1, Eleni Liapi, Josephina A Vossen, Manon Buijs, Veronica Prieto Ventura, Christos Georgiades, Kelvin Hong, Ihab Kamel, Michael S Torbenson, Jean-Francois H Geschwind.   

Abstract

PURPOSE: To test whether different-sized iron oxide-containing Embosphere (IOE) particles can be detected by dedicated magnetic resonance (MR) imaging when injected intraarterially in an animal model of liver cancer and whether their distribution could be accurately predicted by MR imaging before confirmation with histopathologic analysis.
MATERIALS AND METHODS: Twenty New Zealand White rabbits implanted with VX2 liver tumor were randomly assigned to undergo embolization with 100-300-microm particles (group S; n = 10) or 300-500-microm particles (group L; n = 10). Embolization was performed with the catheter placed in the proper hepatic artery. T2*-weighted multiplanar MR imaging was performed within 24 hours after the procedure to detect paramagnetic IOE susceptibility artifact. MR imaging interpretation parameters included presence of artifact in the artery and/or at the tumor bed. Hematoxylin and eosin- and Prussian blue-stained pathologic slides were also obtained and the presence of IOE was evaluated similarly.
RESULTS: The MR detectability rates for IOEs were 100% in both groups. Paramagnetic susceptibility IOE artifact inside the tumor was detected in 30% of group S animals. On pathologic analysis, IOE particles were detected inside the tumor in 70% of this group. IOEs in group L were found outside the tumor within the hepatic artery on MR imaging and histopathologic study (P < .05).
CONCLUSIONS: MR imaging readily detected IOE particles in an animal model of liver cancer regardless of the particle size. The smaller particles (100-300 microm) were delivered inside the tumor or in close proximity to the tumor margin, justifying their use for drug delivery or precise embolization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755602      PMCID: PMC2747287          DOI: 10.1016/j.jvir.2008.06.008

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  22 in total

1.  New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.

Authors:  Kelvin Hong; Afsheen Khwaja; Eleni Liapi; Michael S Torbenson; Cristos S Georgiades; Jean-Francois H Geschwind
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

2.  Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer.

Authors:  Kelvin Hong; Hisham Kobeiter; Christos S Georgiades; Michael S Torbenson; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2005-12       Impact factor: 3.464

3.  Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation.

Authors:  A Laurent; R Beaujeux; M Wassef; D Rüfenacht; E Boschetti; J J Merland
Journal:  AJNR Am J Neuroradiol       Date:  1996-03       Impact factor: 3.825

Review 4.  Biomedical applications of nanotechnology--implications for drug targeting and gene therapy.

Authors:  S S Davis
Journal:  Trends Biotechnol       Date:  1997-06       Impact factor: 19.536

5.  A quantitative study of relaxation rate enhancement produced by iron oxide particles in polyacrylamide gels and tissue.

Authors:  S Majumdar; S Zoghbi; C F Pope; J C Gore
Journal:  Magn Reson Med       Date:  1989-02       Impact factor: 4.668

6.  Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.

Authors:  Mary Maluccio; Anne M Covey; Ripal Gandhi; Mithat Gonen; George I Getrajdman; Lynn A Brody; Yuman Fong; William Jarnagin; Michael D'Angelica; Leslie Blumgart; Ronald DeMatteo; Karen T Brown
Journal:  J Vasc Interv Radiol       Date:  2005-07       Impact factor: 3.464

7.  Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.

Authors:  W Y Lau; S Ho; T W Leung; M Chan; R Ho; P J Johnson; A K Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-02-01       Impact factor: 7.038

8.  Evaluation of tris-acryl gelatin microsphere embolization with monochromatic X Rays: comparison with polyvinyl alcohol particles.

Authors:  Akira Yamamoto; Shigeki Imai; Makito Kobatake; Takenori Yamashita; Tsutomu Tamada; Keiji Umetani
Journal:  J Vasc Interv Radiol       Date:  2006-11       Impact factor: 3.464

Review 9.  Transcatheter and ablative therapeutic approaches for solid malignancies.

Authors:  Eleni Liapi; Jean-Francois H Geschwind
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

10.  Microscopic analysis of arterial microsphere distribution in rabbit liver and hepatic VX2 tumor.

Authors:  K M Pillai; P E McKeever; C A Knutsen; P A Terrio; D M Prieskorn; W D Ensminger
Journal:  Sel Cancer Ther       Date:  1991
View more
  36 in total

1.  Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?

Authors:  Sieh-Yang Lee; Hsin-You Ou; Chun-Yen Yu; Tung-Liang Huang; Leo Leung-Chit Tsang; Yu-Fan Cheng
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

Review 2.  Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy.

Authors:  Andrew L Lewis; Matthew R Dreher
Journal:  J Control Release       Date:  2012-01-21       Impact factor: 9.776

3.  Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.

Authors:  Rebecca Zener; Hyukjun Yoon; Etay Ziv; Anne Covey; Karen T Brown; Constantinos T Sofocleous; Raymond H Thornton; F Edward Boas
Journal:  Cardiovasc Intervent Radiol       Date:  2019-01-09       Impact factor: 2.740

4.  MR imaging enables measurement of therapeutic nanoparticle uptake in rat N1-S1 liver tumors after nanoablation.

Authors:  Joseph L McDevitt; Samdeep K Mouli; Patrick D Tyler; Weiguo Li; Jodi Nicolai; Daniele Procissi; Ann B Ragin; Y Andrew Wang; Robert J Lewandowski; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2014-05-20       Impact factor: 3.464

5.  Nanocomposite Carriers for Transarterial Chemoembolization of Liver Cancer.

Authors:  Dong-Hyun Kim; Andrew C Larson
Journal:  Interv Oncol 360       Date:  2016-11-17

Review 6.  Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balance.

Authors:  Andrew L Lewis; Sean L Willis; Matthew R Dreher; Yiqing Tang; Koorosh Ashrafi; Bradford J Wood; Elliot B Levy; Karun V Sharma; Ayele H Negussie; Andrew S Mikhail
Journal:  Future Oncol       Date:  2018-06-26       Impact factor: 3.404

Review 7.  Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?

Authors:  Thierry de Baere; Lambros Tselikas; Frederic Deschamps; Valerie Boige; Michel Ducreux; Antoine Hollebecque
Journal:  Hepat Oncol       Date:  2016-03-23

8.  MR imaging of hydrogel filament embolic devices loaded with superparamagnetic iron oxide or gadolinium.

Authors:  Monika Killer; Edward M Keeley; Gregory M Cruise; Anne Schmitt; Mark R McCoy
Journal:  Neuroradiology       Date:  2010-07-13       Impact factor: 2.804

9.  Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment.

Authors:  Pi-Yi Chang; Chun-Chieh Huang; Chao-Hung Hung; Chih-Yung Yu; Ding-Kwo Wu; Jen-I Hwang; Po-Chin Liang; Reng-Hong Wu; Wei-Lun Tsai; Yih-Jyh Lin; Yi-Sheng Liu; Huei-Lung Liang; Rheun-Chuan Lee; Chien-Hung Chen
Journal:  Liver Cancer       Date:  2018-03-29       Impact factor: 11.740

10.  Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.

Authors:  Diane K Reyes; Josephina A Vossen; Ihab R Kamel; Nilofer S Azad; Tamara A Wahlin; Michael S Torbenson; Michael A Choti; Jean-Francois H Geschwind
Journal:  Cancer J       Date:  2009 Nov-Dec       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.